Cloning and sequencing of the cellular-viral junctions from the human adenovirus type 5 transformed 293 cell line

被引:158
作者
Louis, N
Evelegh, C
Graham, FL
机构
[1] MCMASTER UNIV,DEPT BIOL,HAMILTON,ON L8S 4K1,CANADA
[2] MCMASTER UNIV,DEPT PATHOL,HAMILTON,ON L8S 4K1,CANADA
基金
加拿大自然科学与工程研究理事会; 英国医学研究理事会; 美国国家卫生研究院;
关键词
D O I
10.1006/viro.1997.8597
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The human-viral junctions of integrated adenovirus type 5 (Ad5) DNA in 293 cells have been cloned and sequenced. The Ad5 sequences extend from nucleotides (nt) 1 to 4344 and are located in the pregnancy-specific beta-1-glycoprotein 4 (PSG 4) gene. This maps the insertion of Ad5 DNA to human chromosome 19 (19q13.2). The Ad5 sequences are represented as a single collinear insertion of viral DNA with no rearrangements. There were 19 bp of PSG4 DNA deleted at the site of insertion and an extra 3 nt (GTC) at the left viral/cellular junction. A short patch of homology between viral DNA and PSG4 DNA (6 nt with 1 mismatch) was present at the right junction. (C) 1997 Academic Press.
引用
收藏
页码:423 / 429
页数:7
相关论文
共 26 条
[1]   ADENOVIRUS 5 DNA SEQUENCES PRESENT AND RNA SEQUENCES TRANSCRIBED IN TRANSFORMED HUMAN-EMBRYO KIDNEY-CELLS (HEK-AD-5 OR 293) [J].
AIELLO, L ;
GUILFOYLE, R ;
HUEBNER, K ;
WEINMANN, R .
VIROLOGY, 1979, 94 (02) :460-469
[2]  
ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
[3]  
DECAMPIONE MMR, 1983, THESIS MCMASTER U
[4]   CHARACTERISTICS OF A HUMAN CELL LINE TRANSFORMED BY DNA FROM HUMAN ADENOVIRUS TYPE-5 [J].
GRAHAM, FL ;
SMILEY, J ;
RUSSELL, WC ;
NAIRN, R .
JOURNAL OF GENERAL VIROLOGY, 1977, 36 (JUL) :59-72
[5]   CHARACTERIZATION OF AN ADENOVIRUS TYPE-5 MUTANT CARRYING EMBEDDED INVERTED TERMINAL REPEATS [J].
HAJAHMAD, Y ;
GRAHAM, FL .
VIROLOGY, 1986, 153 (01) :22-34
[6]   THE ADENOVIRUS TYPE-5 E1A TRANSCRIPTIONAL CONTROL REGION CONTAINS A DUPLICATED ENHANCER ELEMENT [J].
HEARING, P ;
SHENK, T .
CELL, 1983, 33 (03) :695-703
[7]   Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence [J].
Hehir, KM ;
Armentano, D ;
Cardoza, LM ;
Choquette, TL ;
Berthelette, PB ;
Whitte, GA ;
Couture, LA ;
Everton, MB ;
Keegan, J ;
Martin, JM ;
Pratt, DA ;
Smith, MP ;
Smith, AE ;
Wadsworth, SC .
JOURNAL OF VIROLOGY, 1996, 70 (12) :8459-8467
[8]  
HILT M, ADV PHARM GENE THERA, V40
[9]  
HITT M, 1995, METH MOL G, V7, P13
[10]  
HITT M, 1994, CELL BIOL LAB HDB, V1, P479